R
Rebecca Legarth
Researcher at Statens Serum Institut
Publications - 26
Citations - 701
Rebecca Legarth is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 7, co-authored 12 publications receiving 229 citations. Previous affiliations of Rebecca Legarth include Copenhagen University Hospital.
Papers
More filters
Journal ArticleDOI
Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study
Rebecca Legarth,Magnus Glindvad Ahlström,Gitte Kronborg,Carsten Schade Larsen,Court Pedersen,Gitte Pedersen,Rajesh Mohey,Jan Gerstoft,Niels Obel +8 more
TL;DR: Among HIV-infected individuals estimated median survival time from age 50 years has increased by more than 10 years from 1996–1999 to 2006–2014, but is still substantially lower than in the background population.
Journal ArticleDOI
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
Peter Bager,Jan Wohlfahrt,Jannik Fonager,Morten Rasmussen,Mads Albertsen,Thomas Yssing Michaelsen,Camilla Holten Møller,Steen Ethelberg,Rebecca Legarth,Mia Sarah Fischer Button,Sophie Gubbels,Marianne Voldstedlund,Kåre Mølbak,Robert Skov,Anders Fomsgaard,Tyra Grove Krause +15 more
TL;DR: In this article, an observational cohort study of all SARS-CoV-2-positive cases confirmed by RT-PCR in Denmark, sampled between Jan 1 and March 24, 2021, with 14 days of follow-up for COVID-19 hospitalisation was conducted.
Journal ArticleDOI
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
Peter Bayer,Jan Wohlfahrt,Samir Bhatt,Marc Stegger,Rebecca Legarth,Camilla Holten Møller,Robert Skov,Palle Valentiner-Branth,Marianne Voldstedlund,Thea Kølsen Fischer,Lone Simonsen,Nikolai Kirkby,Marianne Thomsen,Katja Spiess,Ellinor Marving,Nicolai B. Larsen,Troels Lillebaek,Henrik Ullum,Kåre Mølbak,Tyra Grove Krause,Sofie Marie Edslev,Raphael N. Sieber,Anna Cäcilia Ingham,Maria Overvad,Mie Agermose Gram,Frederikke Kristensen Lomholt,Louise Hallundbæk,Caroline Hjorth Espensen,Sophie Gubbels,Mari Karakis,Karina Lauenborg Møller,Stefan Schytte Olsen,Zitta Barrella Harboe,C. Klint Johannesen,Maarten van Wijhe,Jon Gitz Holler,Ram Benny Dessau,Martin Barfred Friis,David Fuglsang-Damgaard,Mette Pinholt,Thomas Vognbjerg Sydenham,J. E. Coia,Ea Sofie Marmolin,Anders Fomsgaard,Jannik Fonager,Morten Rasmussen,Arieh Cohen +46 more
TL;DR: A significantly lower risk of hospitalisation with omicron infection compared with delta infection among both vaccinated and unvaccinated individuals is found, suggesting an inherent reduced severity of omicrons.
Journal ArticleDOI
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
Mie Agermose Gram,Hanne-Dorthe Emborg,Astrid Blicher Schelde,N.U. Friis,K. F. Nielsen,I. R. Moustsen-Helms,Rebecca Legarth,J. U. H. Lam,Manon Chaine,Aisha Zahoor Malik,Morten Rasmussen,Jannik Fonager,Raphael N. Sieber,Marc Stegger,Steen Ethelberg,Palle Valentiner-Branth,Christian Holm Hansen +16 more
TL;DR: Two vaccine doses provided high protection against SARS-CoV-2 infection and COVID-19 hospitalization with the Alpha and Delta variants with protection, notably against infection, waning over time.
Posted ContentDOI
Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection
Marc Stegger,Sofie Marie Edslev,Raphael N. Sieber,Anna Cäcilia Ingham,Kim Lee Ng,Manjuan Tang,Soren Alexandersen,Jannik Fonager,Rebecca Legarth,Magdalena Utko,Bartlomiej Wilkowski,Vithiagaran Gunalan,Marc Bennedbæk,Jonas Byberg-Grauholm,Camilla Holten Møller,Lars E. Christiansen,Christina Wiid Svarrer,Kirsten M. Ellegaard,Sharmin Baig,Thor Bech Johannesen,Laura Espenhain,Robert Skov,Arieh Cohen,Nicolai B. Larsen,Karina Meden Sørensen,Erik D. White,Troels Lillebaek,Henrik Ullum,Tyra Grove Krause,Anders Fomsgaard,Steen Ethelberg,Morten Rasmussen +31 more
TL;DR: Evidence is provided that Omicron BA.2 reinfections do occur shortly after BA.1 infections but are rare, mostly in young unvaccinated individuals with mild disease not resulting in hospitalization or death.